Latin America Protein Expression Market

Latin America Protein Expression Market Size (2024 to 2029)

The size of the Protein Expression Market in Latin America was worth USD 277.34 Million in 2024 and is estimated to be growing at a CAGR of 9.81%, to reach USD 442.81 Million by 2029.

Protein expression is a vital element of proteomics that plays an important role in research by allowing the expression of genetically engineered recombinant proteins in various host cells.

Proteins are regulated and manufactured depending upon the functional need in the host cell. Biotechnology-based companies are developing novel therapeutics with minimal side effects, thereby creating a huge Protein expression market.

Factors such as the concentration of large firms in establishing their production units in the region, as well as increasing disposable incomes, increasing geriatric population, high prevalence of chronic diseases such as cancer, neuromuscular disorder, and inflammatory diseases, etc., favorable spending on protein research and the rising funds associated with the production and distribution of protein products are driving the growth of the Latin American protein expression market. Cuba had the highest recorded cancer rate, according to a recent study, with the disease affecting 140 men and 95 women per 100,000 population. While Mexico had the lowest cancer rate with 65 men per 100,000 population and 612 women per 100,000 population. Cancer-associated with stomach, colorectal, lung, and breast are most common in the Latin American region. According to World Bank statistics, current health expenditure (% of GDP) in the world increased from 9.22% in 2002 to 9.94% in 2020. In addition, current health expenditure per capita has increased from 495.99 USD in 2002 to 1,115.84 USD in 2020. These numbers explain the growing demand for healthcare and consecutively is driving the Latin America protein expression market during the studied period.

There is a growing demand for protein products using hi-end molecular biology techniques such as systems biology, metabolic engineering, etc., and the technological advancements in mass spectrometry, protein purification to improve the performance of bioprocesses and generate stable and biologically active proteins with longer shelf life. In addition, rapid developments in medical technology, accurate diagnosis, and the presence of well-developed healthcare services in emerging markets are expected to positively impact the market.

However, several factors such as the high cost of protein expression reagents and instruments coupled with increasing consolidation, a significant shortage of trained health professionals, the lack of local expertise, and lack of efficient systems for post-translational modifications are the major limiting factors in the LATAM protein expression market during the analysis period.

This research report on the Latin America Protein Expression Market has been segmented and sub-segmented into the following categories.

Latin America Protein Expression Market Analysis By Expression Systems

• Yeast Expression

• Insect Expression

• Cell-Free Expression

• Bacterial Expression

• Algal Expression

• Mammalian Expression

Latin America Protein Expression Market Analysis By-Products

• Reagents

• Services

• Instruments

• Others

Latin America Protein Expression Market Analysis By Application

• Industrial Proteins

• Cell Culture

• Research

• Therapeutic Proteins

• Transfection Technologies

• Others

Latin America Protein Expression Market Analysis By End User

• Biotechnology

• Pharmaceutics

• Academia

By Country: 

• Mexico

• Brazil

• Argentina

• Chile

• Rest of Latin America

In the Latin American protein expression market, Brazil presents significant opportunities for the major players and this can be attributed to the high number of university research institutes and pharmaceutical and biotechnology companies in the region. In the Latin American market, the Brazilian protein expression market is expected to experience an annual growth rate of 6.6% during the forecast period. Moreover, increasing healthcare expenditure and increasing applications of protein expression is another important factor responsible for market growth.

The Mexican protein expression market is expected to experience a significant CAGR of 9.2% during the forecast period. The pharmaceutical and biotechnology companies are expected to contribute maximum to the market. The Mexican region established the first proteomics companies established in Latin America. The presence of these companies allows consumers to easily access these products. The increasing collaborations between research institutes and major market players aimed to promote the field of proteomics are mainly driving the growth of the LATAM protein expression market over the projected period. The region also has increased manufacturing of recombinant therapeutic proteins for the treatment of diseases, which will further the research on protein expression.

Other Latin American countries such as Argentina, Columbia, and Peru have key market players in the regions with developed proteomics laboratories. The standardization of the various quantitative proteomics techniques and regulatory authorities has encouraged protein analysis, recombinant protein technique, and protein modification process. Several medical institutions in Mexico are increasingly contributing to the development of proteomics and its applications in different sectors. The increasing R&D activities of various institutions are expected to increase the growth of the Latin American protein expression market during the forecast period.

KEY MARKET PLAYERS

Companies playing a prominent role in the Latin America Protein Expression Market profiled in the report are Agilent Technologies, Life Technologies Corporation, Bio-Rad Laboratories, New England BioLabs, Merck Millipore, Takara Bio, Thermo Fisher Scientific, and Promega Corporation.